Seattle, WA
Summary
This business focuses on harnessing the power of the adaptive immune system to develop innovative diagnostic and therapeutic solutions. It offers a range of services including immune medicine platform development, clinical testing, and drug discovery, specifically targeting minimal residual disease (MRD) assessment and T-cell receptor therapeutics. The company aims to transform disease detection and treatment through advanced immune receptor data and technology.
Based on content on adaptivebiotech.com
cofactorgenomics.com
St. Louis, Missouri
Biotechnology and healthcare diagnostics.
We offer API access to our data.
8 of 8 checks passed
Label
Value
Active Dates
16.5 years — Since Jun 2008
Web Hosting
Platform
E-Mail Provider
NAICS Code
541714
SIC 4 Digit Code
8731
SIC 2 Digit Code
87
Industry
1. Biotechnology and Healthcare
2. Research and Development in Biotechnology (except Nanobiotechnology)
Vendor
Source
GlobalSign
TXT Record
AbuseIPDB
TXT Record
Adobe identity provider
TXT Record
Apple
TXT Record
Atlassian
TXT Record
DocuSign
TXT Record
TXT Record
Intersight
TXT Record
Miro
TXT Record
Pardot
TXT Record
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2008 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2009 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2010 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2011 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2012 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2013 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2014 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2015 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2016 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2017 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2018 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2019 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2020 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2021 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2022 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2023 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2024 |
|
|
|
|
|
|
|
|
|
|
|
|